Menu Menu

RYTM    Rhythm Pharmaceuticals Inc    1649904    
Income Statement
Revenue 33,251,000
Net Income -43,641,000
Profit Margin -131.25%

Balance Sheet
Current Assets 340,341,000
Assets 363,572,000
Current Liabilities 97,605,000
Liabilities 352,357,000
Equity 11,215,000
Shares Out 61,134,000

Cash Flow Statement
Operating Cash Flow -95,034,000
Investing Cash Flow -69,330,000

Market Analysis
Market Cap 3,320,786,367
Price 54.54
BVPS 0.18
PB 297.38
EPS -4.37
PS 2.97
FCF -164,364,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/22 -0.70
Apr May Jun
5/07 -2.35
Jul Aug Sep
8/06 -0.55
Oct Nov Dec
11/6 -0.73

Find a discrepancy? The most accurate way to find company fundamental data is to view RYTM documents filed with the SEC.


RYTM Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: